Complete durable response of a pediatric anaplastic oligodendroglioma to temozolomide alone: Case report and review of literature
- PMID: 28696020
- PMCID: PMC8408833
- DOI: 10.1002/pbc.26708
Complete durable response of a pediatric anaplastic oligodendroglioma to temozolomide alone: Case report and review of literature
Abstract
Anaplastic oligodendroglioma (AO) is rare in children. Treatment typically consists of varying combinations of surgery, chemotherapy, and radiotherapy. We present a pediatric case of frontal lobe AO with periventricular subcallosal extension and local leptomeningeal involvement. The isocitrate dehydrogenase (IDH) wild-type tumor was MGMT methylated and contained an ATRX mutation, BRAF alteration, and 1p/19q co-deletion; a combination of alterations mostly encountered in pediatric oligodendrogliomas. The patient underwent a near total resection and had a complete, durable response to temozolomide alone, suggesting that conservative management without radiation may be appropriate in some cases. We review the literature of this uncommon subtype of glioma in children.
Keywords: 1p19q; children; codeletion; oligodendroglioma; pediatric; temozolomide.
© 2017 Wiley Periodicals, Inc.
Conflict of interest statement
CONFLICT OF INTEREST
The authors declare that there is no conflict of interest.
Figures
References
-
- Creach KM, Rubin JB, Leonard JR, et al.Oligodendrogliomas in children. J Neurooncol 2012;106(2):377–382. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
